Suppr超能文献

应用吲哚菁绿近红外荧光成像检测肝细胞癌:其作用及局限性。

Detection of hepatocellular carcinomas with near-infrared fluorescence imaging using indocyanine green: its usefulness and limitation.

机构信息

Second Department of Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.

出版信息

Int J Clin Oncol. 2013 Apr;18(2):232-41. doi: 10.1007/s10147-011-0367-3. Epub 2011 Dec 27.

Abstract

BACKGROUND

Indocyanine green (ICG), an agent for measuring liver function, becomes fluorescent under near-infrared (NIR) light after binding to serum proteins. Hepatocellular carcinoma (HCC) with a deposit of preoperatively administered ICG becomes clearly detectable under ICG fluorography; however, it remains unclear whether this detection method is always reliable. This case series study was designed to clarify the reliability of this method.

METHODS

ICG (0.5 mg/kg) was injected from the 3rd to 28th preoperative day to evaluate hepatic function in 58 patients with HCCs. Preoperative imaging modalities identified 76 HCC foci. The operative fields and resected specimens were observed with an NIR camera system. Preoperatively detected lesions and lesions newly detected by the ICG fluorography were histologically investigated.

RESULTS

ICG fluorography identified 73 of 76 preoperatively diagnosed HCC lesions. Intraoperative ICG fluorography visualized 47 lesions in 40 patients. The other 26 lesions showing emission were found in the sectioned specimens under NIR observation. Other than preoperatively diagnosed foci, ICG fluorography visualized 35 new lesions, including 6 HCCs, 2 dysplastic nodules and 27 non-neoplastic lesions, such as bile plugs and cysts. The sensitivity of ICG fluorography for HCCs was 96% and its positive predictive value was 71.5%.

CONCLUSIONS

Indocyanine green fluorography is useful to detect HCCs; however, attention should be paid to the fact that HCCs may be occasionally overlooked by this imaging method and that lesions detected by this method are not always neoplastic lesions.

摘要

背景

吲哚菁绿(ICG)是一种测量肝功能的试剂,与血清蛋白结合后在近红外(NIR)光下会发出荧光。术前给予的 ICG 在肝癌(HCC)中的沉积会使 ICG 荧光成像下的 HCC 明显可检测;然而,这种检测方法是否始终可靠仍不清楚。本病例系列研究旨在阐明这种方法的可靠性。

方法

58 例 HCC 患者从第 3 天至第 28 天术前每天注射 0.5mg/kg 的 ICG 以评估肝功能。术前影像学检查确定了 76 个 HCC 病灶。用近红外摄像机系统观察手术野和切除标本。用组织学方法对术前检测到的病变和 ICG 荧光成像新检测到的病变进行研究。

结果

ICG 荧光成像可识别 76 个术前诊断 HCC 病变中的 73 个。术中 ICG 荧光成像可在 40 例患者中可视化 47 个病灶。其他 26 个发射的病灶是在 NIR 观察下的切片标本中发现的。除了术前诊断的病灶外,ICG 荧光成像还可视化了 35 个新病灶,包括 6 个 HCC、2 个异型结节和 27 个非肿瘤性病变,如胆汁栓和囊肿。ICG 荧光成像对 HCC 的敏感性为 96%,阳性预测值为 71.5%。

结论

吲哚菁绿荧光成像有助于检测 HCC;然而,应注意到,这种成像方法偶尔可能会忽略 HCC,并且该方法检测到的病变不一定是肿瘤性病变。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验